Abstract
Keratocytes, the resident cells of the corneal stroma, are responsible for maintaining turnover of this tissue by synthesizing extracellular matrix components. When the cornea is injured, the keratocytes migrate to the wounded site and participate in the stromal wound healing. The neuropeptide substance P (SP), which is also known to be produced by non-neuronal cells, has previously been implicated in epithelial wound healing after corneal injury. Corneal scarring, which occurs in the stroma when the process of wound healing has malfunctioned, is one of the major causes of preventable blindness. This study aimed to elucidate the potential role of SP in keratocyte migration and therefore in stromal wound healing. We report that the expression and secretion of SP in human keratocytes are increased in response to injury in vitro. Moreover, SP enhances the migration of keratocytes by inducing the actin cytoskeleton reorganization and focal adhesion formation through the activation of the phosphatidylinositide 3-kinase and Ras-related C3 botulinum toxin substrate 1/Ras homolog gene family, member A pathway. Furthermore, SP stimulation leads to upregulated expression of the proinflammatory and chemotactic cytokine interleukin-8 (IL-8), which also contributes significantly to SP-enhanced keratocyte migration and is able to attract neutrophils. In addition, the preferred SP receptor, the neurokinin-1 receptor, is necessary to induce keratocyte migration and IL-8 secretion. In conclusion, we describe new mechanisms by which SP enhances migration of keratocytes and recruits neutrophils, two necessary steps in the corneal wound-healing process, which are also likely to occur in other tissue injuries.
Footnotes
- Received July 24, 2015.
- Accepted November 16, 2015.
This work was supported by the national Swedish Research Council [Grant 521-2013-2612]; the J. C. Kempe and Seth M. Kempe Memorial Foundations [Grant JCK-1222]; the Swedish Society of Medicine [Grants SLS-176511, SLS-248321, SLS-329341, SLS-410021]; the Cronqvist foundation [Grants SLS-120651, SLS-249071, SLS-329561]; the foundation Kronprinsessan Margaretas Arbetsnämnd för synskadade [Grants 2010/30, 2012/26, 2013/10]; the foundation Ögonfonden; Västerbotten County Council ‘Spjutspetsmedel’; and a regional agreement (ALF) between Umeå University and Västerbotten County Council.
Preliminary data from this work were presented by Słoniecka et al. in poster sessions at the following meetings: The Association for Research in Vision and Ophthalmology Annual Meeting, May 4–8, 2014; Orlando, Florida, and the Wound Healing Society Annual Meeting, San Antonio, Texas, April 29–May 3, 2015. These studies are part of the PhD, thesis work of Marta Słoniecka, Umeå University, December 2015.
↵
This article has supplemental material available at molpharm.aspetjournals.org.
- Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|